BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 26791860)

  • 21. HLA-DPB1 mismatch induces a graft-versus-leukemia effect without severe acute GVHD after single-unit umbilical cord blood transplantation.
    Yabe T; Azuma F; Kashiwase K; Matsumoto K; Orihara T; Yabe H; Kato S; Kato K; Kai S; Mori T; Morishima S; Satake M; Takanashi M; Nakajima K; Morishima Y;
    Leukemia; 2018 Jan; 32(1):168-175. PubMed ID: 28652579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical amino acid variants in HLA-DRB1 allotypes in the development of Graves' disease and Hashimoto's thyroiditis in the Japanese population.
    Katahira M; Ogata H; Takashima H; Ito T; Hodai Y; Miwata T; Goto M; Yamaguchi M; Mizoguchi A; Kawakubo M; Nakamura S
    Hum Immunol; 2021 Apr; 82(4):226-231. PubMed ID: 33386169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study.
    Heward JM; Allahabadia A; Daykin J; Carr-Smith J; Daly A; Armitage M; Dodson PM; Sheppard MC; Barnett AH; Franklyn JA; Gough SC
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3394-7. PubMed ID: 9768636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of HLA in hematopoietic SCT.
    Nowak J
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S71-6. PubMed ID: 18978750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of Mismatched HLA on the Leukemic Blasts of Patients With Relapsed Lymphoid Malignancies Following Bone Marrow Transplantation From Related Donors With HLA Class II Mismatches in the Graft Versus Host Direction.
    Hirabayashi K; Kurata T; Horiuchi K; Saito S; Shigemura T; Tanaka M; Yanagisawa R; Matsuda K; Sakashita K; Koike K; Nakazawa Y
    Pediatr Blood Cancer; 2016 Apr; 63(4):709-11. PubMed ID: 26544669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens.
    Fuchs KJ; Honders MW; van der Meijden ED; Adriaans AE; van der Lee DI; Pont MJ; Monajemi R; Kielbasa SM; 't Hoen PAC; van Bergen CAM; Falkenburg JHF; Griffioen M
    Front Immunol; 2020; 11():659. PubMed ID: 32362897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MHC-extended haplotypes in families of patients with Graves' disease.
    Ratanachaiyavong S; Lloyd L; Darke C; McGregor AM
    Hum Immunol; 1993 Feb; 36(2):99-111. PubMed ID: 8096501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Tomer Y; Davies TF
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of independent susceptible and protective HLA alleles in Japanese autoimmune thyroid disease and their epistasis.
    Ueda S; Oryoji D; Yamamoto K; Noh JY; Okamura K; Noda M; Kashiwase K; Kosuga Y; Sekiya K; Inoue K; Yamada H; Oyamada A; Nishimura Y; Yoshikai Y; Ito K; Sasazuki T
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E379-83. PubMed ID: 24285682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
    Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
    Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor T cells administered over HLA class II barriers mediate antitumor immunity without broad off-target toxicity in a NOD/scid mouse model of acute leukemia.
    Stevanović S; Nijmeijer BA; van Schie ML; Salvatori DC; Maas S; Griffioen M; Falkenburg JH
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):867-75. PubMed ID: 23500532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation.
    Hosseini E; Schwarer AP; Ghasemzadeh M
    Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):15-21. PubMed ID: 22427472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA alleles, especially amino-acid signatures of HLA-DPB1, might contribute to the molecular pathogenesis of early-onset autoimmune thyroid disease.
    Shin DH; Baek IC; Kim HJ; Choi EJ; Ahn M; Jung MH; Suh BK; Cho WK; Kim TG
    PLoS One; 2019; 14(5):e0216941. PubMed ID: 31091281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MHC haplotype matching for unrelated hematopoietic cell transplantation.
    Petersdorf EW; Malkki M; Gooley TA; Martin PJ; Guo Z
    PLoS Med; 2007 Jan; 4(1):e8. PubMed ID: 17378697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of killer immunoglobulin-like receptor-ligand interactions in human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.
    Kanga U; Mourya M; Seth T; George J; Sood P; Sharma R; Saxena A; Mehra NK
    Transplant Proc; 2012 May; 44(4):919-21. PubMed ID: 22564585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do human leukocyte antigen E polymorphisms influence graft-versus-leukemia after allogeneic hematopoietic stem cell transplantation?
    Hosseini E; Schwarer AP; Ghasemzadeh M
    Exp Hematol; 2015 Mar; 43(3):149-57. PubMed ID: 25434712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
    Sellami MH; Bani M; Torjemane L; Kaabi H; Ladeb S; Ben Othmane T; Hmida S
    Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy.
    Shichi D; Kikkawa EF; Ota M; Katsuyama Y; Kimura A; Matsumori A; Kulski JK; Naruse TK; Inoko H
    Tissue Antigens; 2005 Sep; 66(3):200-8. PubMed ID: 16101831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a Hashimoto thyroiditis susceptibility locus via a genome-wide comparison with Graves' disease.
    Oryoji D; Ueda S; Yamamoto K; Yoshimura Noh J; Okamura K; Noda M; Watanabe N; Yoshihara A; Ito K; Sasazuki T
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E319-24. PubMed ID: 25429627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors.
    Greinix HT; Faé I; Schneider B; Rosenmayr A; Mitterschiffthaler A; Pelzmann B; Kalhs P; Lechner K; Mayr WR; Fischer GF
    Bone Marrow Transplant; 2005 Jan; 35(1):57-62. PubMed ID: 15531903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.